U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Malignant tumor of urinary bladder

Malignant tumor of urinary bladder

Synonyms
Bladder cancer; Urinary Bladder Neoplasms; Urinary bladder cancer

Summary

A primary or metastatic malignant neoplasm involving the bladder. [from NCI]

Available tests

146 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Clinical tests (146 available)

Cytogenetics Tests

Molecular Genetics Tests

Genes See tests for all associated and related genes

  • Also known as: ACH, CD333, CEK2, HSFGFR3EX, JTK4, FGFR3
    Summary: fibroblast growth factor receptor 3

  • Also known as: C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, RASH1, p21ras, HRAS
    Summary: HRas proto-oncogene, GTPase

  • Also known as: 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, K-Ras, K-Ras 2, KI-RAS, KRAS1, KRAS2, NS, NS3, OES, RALD, RASK2, c-Ki-ras, c-Ki-ras2, KRAS
    Summary: KRAS proto-oncogene, GTPase

  • Also known as: OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb, pp110, RB1
    Summary: RB transcriptional corepressor 1

Clinical features

Help
Imported from Human Phenotype Ontology (HPO)

Show allHide all

Reviews

Clinical resources

Practice guidelines

  • NICE, 2023
    UK NICE Guideline NG12, Suspected cancer: recognition and referral, 2023
  • NCCN, 2023
    NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Bladder Cancer, 2023

Molecular resources

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.